🇺🇸 FDA
Patent

US 10500271

Compositions and methods for self-adjuvanting vaccines against microbes and tumors

granted A61KA61K2039/5256A61K2039/55516

Quick answer

US patent 10500271 (Compositions and methods for self-adjuvanting vaccines against microbes and tumors) held by The Regents of the University of California expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/5256, A61K2039/55516, A61K35/763, A61K39/39